Stryker Corp

SYK

Equity

ISIN US8636671013 / Valor 974330

New York Stock Exchange, Inc (2024-11-19)

USD 388.68-0.18%

Stryker Corp
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Stryker Corp is a prominent player in the medical technology industry, focusing on providing innovative products and services in areas such as MedSurg, Neurotechnology, Orthopaedics, and Spine. The company collaborates with healthcare professionals to enhance patient outcomes and overall healthcare quality. With a global presence, Stryker is dedicated to driving advancements in medical technologies to ultimately improve the quality of healthcare worldwide.

Summarized from source with an LLMView SourceSector: Healthcare

Net Sales Increase

Stryker Corp's net sales for the second quarter of 2024 reached $5,422 million, reflecting a significant increase from the $4,996 million reported in the same quarter of 2023. This growth underscores the company's strong market presence and successful sales strategies.

Gross Profit Growth

In the second quarter of 2024, Stryker Corp reported a gross profit of $3,416 million, up from $3,181 million in the second quarter of 2023. This improvement in gross profit highlights the company's effective cost management and operational efficiency.

Net Earnings Rise

Stryker Corp's net earnings for the second quarter of 2024 were $825 million, compared to $738 million in the same period of 2023. This increase in net earnings demonstrates the company's ability to enhance profitability through strategic initiatives and robust performance.

Earnings Per Share

For the second quarter of 2024, Stryker Corp reported basic earnings per share of $2.17 and diluted earnings per share of $2.14. This is an improvement from the basic earnings per share of $1.95 and diluted earnings per share of $1.93 reported in the second quarter of 2023, indicating strong shareholder value creation.

Dividend Declaration

Stryker Corp declared a cash dividend of $0.80 per share of common stock for the second quarter of 2024, up from $0.75 per share in the second quarter of 2023. This increase in dividends reflects the company's commitment to returning value to its shareholders.

Summarized from source with an LLMView Source

Key figures

34.8%1Y

47.4%3Y

87.7%5Y

Performance

18.6%1Y

25.4%3Y

30.8%5Y

Volatility